Emergence of anxiety-like behaviours in depressive-like Cpe fat/fat mice

International Journal of Neuropsychopharmacology

Volumn 16, Issue 7, 2013, Pages 1623-1634

  Rodriguiz, Ramona M ^a   Wilkins, John J ^a   Creson, Thomas K ^a   Biswas, Reeta ^b   Berezniuk, Iryna ^b   Fricker, Arun D ^b   Fricker, Lloyd D ^b   Wetsel, William C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

carboxypeptidase E; depression; encephalin convertase; Key words Anxiety; neuropeptides; obesity

Indexed keywords

AMFEBUTAMONE; DIAZEPAM; FLUOXETINE; REBOXETINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; FORCED SWIMMING TEST; GROUPS BY AGE; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL; TREATMENT DURATION;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; CARBOXYPEPTIDASE H; DEPRESSION; DIAZEPAM; EXPLORATORY BEHAVIOR; HINDLIMB SUSPENSION; MAZE LEARNING; MICE; MICE, TRANSGENIC; MORPHOLINES; MOTOR ACTIVITY; OBESITY; POINT MUTATION; SWIMMING;

EID: 84880516488     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145713000059     Document Type: Article

References (43)

1. Amico JA, Mantella RC, Vollmer RR, Li X (2004) Anxiety and stress responses in female oxytocin deficient mice. J Neuroendocrinology 16:319-324.
2. Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E, Sulser F (1995) Bupropion: A review of its mechanism of antidepressant activity. J Clin Psychiat 56:395-401.
3. Bannon AW, Seda J, Carmouche M, Francis JM, Norman MH, Karbon B, McCaleb ML (2000) Behavioral characterization of neuropeptide Y knockout mice. Brain Res 868:79-87.
4. Cain BM, Wang W, Beinfeld MC (1997) Cholecystokinin (CCK) levels are greatly reduced in the brains but not the duodenums of Cpefat/Cpefat mice: A regional difference in the involvement of carboxypeptidase E (Cpe) in pro-CCK processing. Endocrinology 138:4034-4037.
5. Cawley NX, Zhou J, Hill JM, Abebe D, Romboz S, Yanik T, Rodriguiz RM, Wetsel WC, Loh YP (2004) The carboxypeptidase E knockout mouse exhibits endocrinological and behavioral deficits. Endocrinology 145:5807-5819.
6. Che F-Y, Biswas R, Fricker LD (2005) Relative quantitation of peptides in wild-type and Cpe(fat/fat) mouse pituitary using stable isotopic tags and mass spectrometry. J Mass Spectrom 40:227-237.
7. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS (2006) Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314:140-143.
8. Crawley JN, Goodwin FK (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13:167-170.
9. Fricker LD (2002) Carboxypeptidases E and D. In : The enzymes, volume 23: Co- and posttranslational proteolysis of proteins (Dalbey RE, Sigman DS, eds), pp421-452. San Diego Academic Press.
10. Fricker LD (2004a) Carboxypeptidase E. In : Handbook of proteolytic enzymes (Barrett AJ, Rawlings ND, Woessner JF, eds), pp840-844. San Diego Academic Press.
11. Fricker LD (2004b) Metallocarboxypeptidase D. In : Handbook of proteolytic enzymes (Barrett AJ, Rawlings ND, Woessner JF, eds), pp848-851. San Diego: Academic Press.
12. Fricker LD, Leiter EH (1999) Peptides, enzymes and obesity : new insights from a 'dead' enzyme. Trends Biochem Sci 24:390-393.
13. Fricker LD, Berman YL, Leiter EH, Devi LA (1996) Carboxypeptidase E activity is deficient in mice with the fat mutation. Effect on peptide processing. J Biol Chem 271:30619-30624.
14. Fukui M, Rodriguiz RM, Jiang SX, Phillips LE, Caron MG, Wetsel WC (2007) Vmat2 heterozygous mutant mice display a depressive-like phenotype. J Neurosci 27:10520-10529.
15. Holmes A, Rodgers RJ (2003) Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine. Eur J Pharmacol 459:221-230.
16. Ko?ning M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, Zimmer A (1996) Pain responses, anxiety and aggression in mice deficient in preproenkephalin. Nature 383:535-538.
17. Ko?ster A, MontkowskiA, Schulz S, Stu? be E-M, Knaudt K, Jenck F, Moreau J-L, Nothacker H-P, Civelli O, Reinscheid RK (1999) Targeted disruption of the orphanin FG/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc Natl Acad Sci USA 96:10444-10449.
18. Leiter EH, Kintner J, Flurkey K, Beamer WG, Naggert JK (1999) Physiologic and endocrinologic characterization of male sex-biased diabetes in C57BLKS/J mice congenic for the fat mutation at the carboxypeptidease E locus. Endocrine 10:57-66.
19. Lim J, Berezniuk I, Che F-Y, Parikh R, Biswas R, Pan H, Fricker LD (2006) Altered neuropeptide processing in prefrontal cortex of Cpefat/fat mice: Implications for neuropeptide discovery. J Neurochem 96:1169-1181.
20. Mantella RC, Vollmer RR, Li X, Amico JA (2003) Female oxytocin-deficient mice display enhanced anxiety-related behavior. Endocrinology 144:2291-2296.
21. Millan MJ (2003) The neurobiology and control of anxious states. Prog Neurobiol 70:83-244.
22. Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, Steiner DF, Carroll RJ, Paigen BJ, Leiter EH (1995) Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 10:135-142.
23. Nemeroff CB, Owens MJ (2002) Treatment of mood disorders. Nat Neurosci 5:1068-1070.
24. Nillni EA, Xie W, Mulcahy L, Sanchez VC, Wetsel WC (2002) Deficiencies in pro-thyrotropin-releasing hormone (pro-TRH) processing and abnormalities in thermoregulation in Cpefat/fat mice. J Biol Chem 277:48587-48595.
25. Pogorelov VM, Rodriguiz RM, Insco MI, Caron MG, Wetsel WC (2005) Novelty-seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology 30:1818-1831.
26. Rovere C, Viale A, Nahon J, Kitabgi P (1996) Impaired processing of brain proneurotensin and promelanin-concentrating hormone in obese fat/fat mice. Endocrinology 137:2954-2958.
27. Seidah NG, Chre'tien M (1999) Proprotein and prohormone convertases: A family of subtilases generating diverse bioactive polypeptides. Brain Res 848:45-62.
28. Seoane LM, Al-Massadi O, Lage M, Dieguez C, Casanueva FF (2004) Ghrelin: From a GH-secretagogue to the regulation of food intake, sleep and anxiety. Pediatr Endocrinol Rev (Suppl. 3) :432-437.
29. Shen F-S, Loh YP (1997) Intracellular misrouting and abnormal secretion of adrenocorticotropin and growth hormone in Cpefat mice associated with a carboxypeptidase E mutation. Proc Natl Acad Sci USA 94:5314-5319.
30. Singh P, Cobb S, Rengifo-Cam W, Deng X, Willis W, Li Q (2004) Locomotor activity and behavior of mutant mice deleted for gastrin gene expression. J Physiol Pharmacol 55:269-278.
31. Srinivasan S, Bunch DO, Feng Y, Rodriguiz RM, Li M, Ravenell RL, Luo GX, Arimura A, Fricker LD, Eddy EM, Wetsel WC (2004) Analysis of the infertility phenotype in male Cpefat/fat mice. Endocrinology 145:2023-2034.
32. Stanek LM (2006) Cocaine- and amphetamine-related transcript (CART) and anxiety. Neuropeptides 27:2005-2011.
33. Strand FL (2003) Neuropeptides : general characteristics and neuropharmaceutical potential in treating CNS disorders. Prog Drug Res 61:1-37.
34. Tollefson GD, Rosenbaum JF (1998) Selective serotonin reuptake inhibitors. In : Textbook of psychopharmacology, Second Edition (Schatzberg AF, Nemeroff CB, eds), pp 219-237. Washington, DC: American Psychiatric Press, Inc.
35. Udupi V, Gomez P, Song L, Varlamov O, Reed JT, Leiter EH, Fricker LD, Greeley GHJ (1997) Effect of carboxypeptidase E deficiency on progastrin processing and gastrin messenger ribonucleic acid expression in mice with the fat mutation. Endocrinology 138:1959-1963.
36. Urani A, Chourbaji S, Gass P (2005) Mutant mouse models of depression: Candidate genes and current mouse lines. Neurosci Biobehav Rev 29:805-828.
37. Valdez GR, Inoue K, Koob GF, Rivier J, Vale W, Zorilla EP (2002) Human urocortin II : Mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res 943:142-150.
38. Varlamov O, Leiter EH, Fricker LD (1996) Induced and spontaneous mutations at Ser202 of carboxypeptidase E. Effect on enzyme expression, activity, and intracellular routing. J Biol Chem 271:13981-13986.
39. Vetter DE, Li C, Zhao L, Contarino A, Liberman MC, Smith GW, Marchuk Y, Koob GF, Heinemann SF, Vale W, Lee K-F (2002) Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nat Genet 31:363-369.
40. Xu Y-L, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, Brucher FA, Zeng J, Ly NK, Henriksen SJ, de Lecea L, Civelli O (2004) Neuropeptide S: A neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43:487-497.
41. Yuan Q, Fontenele-Neto JD, Fricker LD (2004) Effect of voluntary exercise on genetically obese Cpefat/fat mice: quantitative proteomics of serum. Obes Res 12:1179-1188.
42. Zhou A, Webb G, Zhu X, Steiner DF (1999) Proteolytic processing in the secretory pathway. J Biol Chem 274:20745-20748.
43. Zimmerman M, Chelminski I, McDermut W (2002) Major depressive disorder and axis I diagnostic comorbidity. J Clin Psychiatry 63:187-193.